Jeff - A Familial Hypercholesterolemia (FH) Story

Jeff’s dad died of a massive heart attack at 60 and Jeff has always struggled with high cholesterol.  The Kwitowski family didn’t put the pieces together until a specialist diagnosed their firstborn daughter with familial hypercholesterolemia (FH).  FH is a common life-threatening genetic condition that causes high cholesterol.  Left untreated, FH leads to early heart attacks and heart disease.  

Jeff’s story explains why it’s so important that we support medical innovation - and access to new medicines that result from that innovation.

Keith Ferdinand, MD, Discusses Cardiovascular Health

Dr. Ferdinand discusses ending disparities in cardiovascular care and barriers that keep patients from the treatment they need.

High Cholesterol in Europe

Learn about the impact of high cholesterol in Europe in this EAfPA video.

Non-Medical Switching Hurts Patients

In a first-of-its-kind study, the Alliance for Patient Access reveals that non-medical switching, where insurers or pharmacy benefit managers drive stable patients to switch to lower-cost medicines, can levy widespread damage on patients’ quality of life.

The Diabetes-Cardiovascular Connection

People with Type 2 diabetes are twice as likely to have heart disease. But is the health care system set up to effectively manage patients with coexisting conditions?

The Prior Authorization Battle

How insurers' prior authorization requirements burden physicians and blocks heart patients' access to medicine.

2018 Cardiovascular Health Policy Summit

Recap video from the inaugural Cardiovascular Health Policy Summit in Washington, DC.  

Lynne Braun, CNP, PhD, Discusses Cardio Health

Lynne Braun, CNP, PhD, discusses the administrative burden that nurses face when trying to prescribe their patients PCSK9 inhibitors.

The Co-Pay Surprise

AfPA video discusses how co-pay accumulator adjustment programs can impact patients' access to treatment.

Seth Baum, MD, Discusses Cardio Health

Seth Baum, MD, discusses how every one of his patients was denied access to a PCSK9 inhibitor. Now, he's fighting back.

Patient Access to PCSK9 Inhibitors

When health plans boost their bottom line by blocking access to medicine, it's heart patients who pay the price.

Dharmesh Patel, MD, Discusses Cardio Health

Dharmesh Patel, MD, talks about how the use of burdensome utilization management practices such as prior authorization keep potentially life-saving therapies from patients.

Understanding Prior Authorization
What began as a safeguard against unnecessary drug spending has become a significant barrier to patient access.

Accessing Breakthrough Cholesterol Treatments
Health plans deny up to 3 out of every 4 patients who have been prescribed a PCSK9 inhibitor by their doctor.

PCSK9 Inhibitors: Access Barriers Affect Real People
This video, filmed at a town hall hosted by the American Society for Preventive Cardiology (ASPC) in Washington, D.C., highlights not only patient testimonials, but also the concerted effort by health care providers to overcome these remarkable denial rates.